Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,414 across all filing types
Latest filing 2025-02-18 Regulatory Filings
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
Communiqué de presse : La FDA accorde un examen prioritaire à la demande de licence supplémentaire relative au Dupixent pour le traitement ciblé de la pemphigoïde bulleuse
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi and Regeneron announcing that the FDA has granted priority review to their supplemental Biologicals License Application (sBLA) for Dupixent. It details the clinical study results, the nature of the disease, and regulatory status. As this is a standard corporate announcement regarding regulatory progress and product development, it falls under the 'Regulatory Filings' category as a general corporate announcement.
2025-02-18 French
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi and Regeneron announcing that the FDA has accepted their supplemental biologics license application (sBLA) for Dupixent for priority review. This is a standard corporate announcement regarding regulatory progress for a drug candidate. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement (RPA) as it is the primary news release itself. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate regulatory announcement.
2025-02-18 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
Regulatory Filings 2025
Regulatory Filings
2025-02-14 English
IRANNOTICE
Regulatory Filings Classification · 100% confidence The document is a short notice (1141 characters) referencing a disclosure made in the company's Annual Report on Form 20-F for the year ended December 31, 2024. It is a formal notification pursuant to specific regulatory provisions (Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act). The document does not contain the Annual Report itself or substantive financial data but rather informs about the filing of that report. According to the 'Menu vs Meal' rule, such a short notice announcing the filing of a report is classified as a Regulatory Filing (RNS).
2025-02-13 English
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Report Publication Announcement Classification · 100% confidence The document is a short press release (2121 characters) that announces the filing and availability of the company's 2024 Form 20-F and Annual Financial Report. It provides links to where these documents can be accessed rather than containing the reports themselves. Per the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-02-13 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.